Evidence
Am J Psychiatry. 2023 May 1;180(5):340-347. doi: 10.1176/appi.ajp.20230172.
ABSTRACT
Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems-mainly the serotonin 5-HT2A receptor. With the renewed interest in utilizing these compounds as therapeutics and the explosion in clinical trials, psychedelics have been purported to treat many neuropsychiatric disorders, including depression, cluster headaches, migraines, anxiety, and obsessive-compulsive disorder. It is therefore imperative to understand the biology and pharmacology behind their therapeutic mechanisms as well as expose any potential pitfalls in their widespread use as treatments. This review covers the latest advances in understanding the biological mechanisms, the newest efforts in drug discovery, and potential pitfalls when it comes to utilizing this class of compounds as emerging therapeutics.
PMID:37122272 | DOI:10.1176/appi.ajp.20230172
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Psychedelics as Transformative Therapeutics
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
- Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia
- Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia
- Integrating Polygenic Scores and Phenotypic Data to Understand Psychiatric Outcomes
- 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase
- Effects of classic psychedelic drugs on turbulent signatures in brain dynamics
- The Developmental Trajectory to Cannabis Use Disorder
- The Developmental Trajectory to Cannabis Use Disorder
- Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
- The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment
- In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
- Drug repurposing for cancer
- Drug repurposing for cancer
- The More Things Change .
- Multi-target drugs for Alzheimer's disease
- Network Connection Issues in ADHD
- Advances in Understanding Schizophrenia, ADHD, and ASD
- ADHD and ASD: Time to Split or Lump?
- Primordial Origins of RNA Therapeutics
- Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?
- Cognitive Remediation in Schizophrenia Spectrum Illness: Evidence for Treatment Persistence
- Aligning Stem Cell Models and Postmortem Studies to Query Striatal Neurodevelopment in Schizophrenia
- Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia
- Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening
- Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics
- Stutterers' experiences on classic psychedelics: A preliminary self-report study
- Do classic psychedelics increase the risk of seizures? A scoping review
- Do classic psychedelics increase the risk of seizures? A scoping review
- RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine
- Nutritional profiling and in silico analysis of pharmacological activities from local rice Pulu Mandoti fermented with Pleurotus spp
- Therapeutic potential of Bergenin in the management of neurological-based diseases and disorders
- Ethox Seminar – The Ethics of Transformative Experience and Psychotherapy
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
- International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
- XOB: A novel phenylalkylamine antagonist of 5-HT2A receptors and voltage-gated sodium channels
- Cryo-EM structures elucidate the multiligand receptor nature of megalin
- Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis
- Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits
- Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits
- Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness
- Curcumin and nano-curcumin applications in psychiatric disorders
- Network Pharmacology and Molecular Docking Integrated with Molecular Dynamics Simulations Investigate the Pharmacological Mechanism of Yinchenhao Decoction in the Treatment of Non-alcoholic Fatty Liver Disease
- Network Pharmacology and Molecular Docking Integrated with Molecular Dynamics Simulations Investigate the Pharmacological Mechanism of Yinchenhao Decoction in the Treatment of Non-alcoholic Fatty Liver Disease
- Current state of clinical ultrasound neuromodulation
- Current state of clinical ultrasound neuromodulation
- Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis
- Effects and safety of transcranial direct current stimulation on multiple health outcomes: an umbrella review of randomized clinical trials
- Population-based cohort study of Toxoplasma gondii P22 antibody positivity correlation with anxiety
- Neuroprotective compounds alter the expression of genes coding for proteins related to mitochondrial function in activated microglia
- Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease
- An Extensive Review on Lung Cancer Therapeutics Using Machine Learning Techniques: State-of-the-art and Perspectives
- Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease
- Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety
- How to treat subsyndromal anxiety disorder - practical recommendations for implementation in primary care
- Phytocannabinoids in neuromodulation: from omics to epigenetics
- Generative design of compounds with desired potency from target protein sequences using a multimodal biochemical language model
- Psychopharmacology Review for Eating Disorders Among Children, Adolescents, and Adults
- Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets
- Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets
- Post-transcriptional dysregulation in autism, schizophrenia, and bipolar disorder
Evidence Blueprint
Psychedelics as Transformative Therapeutics
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Psychedelics as Transformative Therapeutics
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
- Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential
- Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders
- Bedside to bench: the outlook for psychedelic research
- The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
- Overview of Alcohol Use Disorder
- Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence
- Psychedelics for Alzheimer's Disease-Related Dementia: Unveiling Therapeutic Possibilities and Pathways
- Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
- Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives
- Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain
- RNA therapeutics for neurological disease
- Substance Use Disorders Are Psychiatric Disorders
- Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction
- New Insights Into Psychotic Disorders
- The First Large GWAS Meta-Analysis for Postpartum Depression
- Adversity and Resilience, Postpartum Depression, Suicide, and Racial/Ethnic Disparities
- Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression
- Alcohol Consumption and Alcohol Use Disorder: Exposing an Increasingly Shared Genetic Architecture
- Psychedelia: The interplay of music and psychedelics
- Correction to Guintivano et al
- Sexual Orientation and Suicidal Behavior: Is It Getting Better?
- Predicting Conversion to Psychosis Using Machine Learning: Are We There Yet?
- Perinatal Mental Health: Advances and Opportunities
- Another Step Toward the Prediction of Antipsychotic Treatment Response Using Functional Connectivity
- Trends in Suicide Among Black Women in the United States, 1999-2020
- Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
- Early-life Adversity and Genetics Associated With the Risk to Develop Psychiatric Illnesses
- A Mental Health Crisis and Call to Action: Increasing Trends in Suicide Among Black Women in the United States
- Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia
- Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia
- Cardiovascular safety of psychedelic medicine: current status and future directions
- Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
- Integrating Polygenic Scores and Phenotypic Data to Understand Psychiatric Outcomes
- Addiction specialists' attitudes toward psychedelics: A National Survey
- The bodily self from psychosis to psychedelics
- 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase
- Effects of classic psychedelic drugs on turbulent signatures in brain dynamics
- Psychedelics to Relieve Psychological Suffering Associated with a Life-Threatening Diagnosis: Time for a Canadian Policy Discussion
- Identification of drug repurposing candidates for the treatment of anxiety: A genetic approach
- Improvement in OCD symptoms associated with serotoninergic psychedelics: a retrospective online survey
- The Developmental Trajectory to Cannabis Use Disorder
- The Developmental Trajectory to Cannabis Use Disorder
- Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
- The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Psychedelics and neonihilism: connectedness in a meaningless world
- Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
- Pharmacology of platelet immune receptors: mechanisms of activation and development of therapeutics
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
- Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?
- Drug repurposing for cancer
- Drug repurposing for cancer
- Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
- The More Things Change .
- Multi-target drugs for Alzheimer's disease
- Network Connection Issues in ADHD
- Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention